Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
Open Access
- 29 October 2010
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 9 (1) , 70
Abstract
Background: The aim of the present cross-sectional study was to assess possible associations between osteopontin (OPN), and thrombin-cleaved (N-half) OPN, and nephropathy and coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM). Methods: Plasma levels of OPN, N-half OPN, and high-sensitivity C-reactive protein (hsCRP) were determined in 301 diabetic patients with (n = 226) or without (n = 75) angiographically documented CAD (luminal diameter narrowing >50%), as well as in 75 non-diabetic controls with normal angiography. The estimated glomerular filtration rate (eGFR) was calculated in all patients. Results: Plasma levels of OPN and hsCRP were significantly higher in patients with T2DM compared with controls. In addition, there was a higher occurrence of moderate renal insufficiency and lower eGFR in patients with T2DM (all P < 0.01). T2DM patients in whom OPN levels were greater than the median value had higher serum creatinine levels, a greater prevalence of mild or moderate renal insufficiency, a higher incidence of CAD, and lower eGFR (all P < 0.05) than T2DM patients in whom OPN levels were the same as or lower than the median value. However, there were no differences in these parameters when patients were stratified according to plasma N-half OPN levels. Furthermore, there was a significant correlation between OPN, but not N-half OPN, and the severity of nephropathy and CAD in diabetes. After adjustment for potential confounders and treatments, multiple linear regression analysis demonstrated an independent association between OPN, but not N-half OPN, and eGFR. Multivariate logistic regression revealed that higher OPN levels conferred a fourfold greater risk of renal insufficiency and CAD in patients with T2DM. Conclusions: The results of the present study demonstrate that there is an independent association between plasma levels of OPN, but not N-half OPN, and the presence and severity of nephropathy and CAD in diabetes.Keywords
This publication has 38 references indexed in Scilit:
- Nuclear Factor of Activated T Cells Regulates Osteopontin Expression in Arterial Smooth Muscle in Response to Diabetes-Induced HyperglycemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Polymeric Osteopontin Employs Integrin α9β1 as a Receptor and Attracts Neutrophils by Presenting a de Novo Binding SiteJournal of Biological Chemistry, 2009
- The Pathologic Continuum of Diabetic Vascular DiseaseJACC, 2009
- YKL-40 - an emerging biomarker in cardiovascular disease and diabetesCardiovascular Diabetology, 2009
- Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patientsCardiovascular Diabetology, 2009
- Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2Cardiovascular Diabetology, 2009
- The Role of Osteopontin in the Development of AlbuminuriaJournal of the American Society of Nephrology, 2008
- The prevalence of macrovascular complications among diabetic patients in the United Arab EmiratesCardiovascular Diabetology, 2007
- Expression, roles, receptors, and regulation of osteopontin in the kidneyKidney International, 2001
- Enhanced Expression of Osteopontin by High Glucose in Cultured Rat Aortic Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1999